Archive for: October 2007

HealthDay - TUESDAY, Oct. 30 (HealthDay News) -- Among prostate cancer patients undergoing a high-tech form of radiation therapy, exposure to a higher amount of radiation over a shorter time span poses no added risk for impaired sexual function, new research reveals.

HealthDay - MONDAY, Oct. 29 (HealthDay News) High-dose precision radiation therapy doesn't harm the sexual function of prostate cancer patients, U.S. researchers say.

HealthDay - WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report.

Reuters - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy.

HealthDay - TUESDAY, Oct. 9 (HealthDay News) -- Prostate cancer patients receiving androgen-deprivation therapy, a common form of hormone treatment proven to slow tumor growth and prolong life, may face a nearly threefold higher risk of dying from heart disease, a new study suggests.

HealthDay - MONDAY, Oct. 8 (HealthDay News) -- Surgery may offer the best chance of long-term survival for prostate cancer patients, a Swiss study suggests.

Reuters - Men have the best chance of surviving prostate cancer in the long run if the gland is removed, particularly if they are younger or the cancer is aggressive, a study said on Monday.

HealthDay - SUNDAY, Oct. 7 (HealthDay News) -- For several years, doctors have debated the value of the prostate-specific antigen test to determine a man's risk for prostate cancer.

HealthDay - SUNDAY, Oct. 7 (HealthDay News) -- Men diagnosed with prostate cancer in the summer and fall have a better chance of survival than those diagnosed in the spring and winter, a new study of Norwegian men suggests.

Reuters - A new study refutes the long-held belief that prostate cancer tumors are more aggressive in African-American men than in Caucasian men.